Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

238 ARTÍCULOS , VIENDO DEL 181 AL 195

Novel Genetic and Phenotypic Expansion in GOSR2-Related Progressive Myoclonus Epilepsy

Hentrich L, Parnes M, Lotze TE, Coorg R, de Koning TJ, Nguyen KM, Yip CK, Jungbluth H, Koy A, Dafsari HS.

Genes (Basel). 2023 Sep 25;14(10):1860. doi: 10.3390/genes14101860.

Novel Pathogenic Variant in the NEU1 Gene in a Patient With Sialidosis With Progressive Myoclonus Ataxia With Cherry-Red Spot

Sahoo LK, Kota V, Panigrahi PK, Pattnaik S, Mishra AP, Sahoo SK; as the SUM Neuro-opthalmology Study Group.

Neurology. 2023 Nov 7;101(19):861-862. doi: 10.1212/WNL.0000000000207715. Epub 2023 Aug 21.

Neuroblastic Tumor Recurrence Associated With Opsoclonus Myoclonus Ataxia Syndrome Relapse a Decade After Initial Resection and Treatments

Bacchus MK, Anderson DS, Berko ER, States LJ, Bagatell R, Hopkins SE, Batra V.

J Pediatr Hematol Oncol. 2023 Apr 1;45(3):152-154. doi: 10.1097/MPH.0000000000002643. Epub 2023 Feb 20.

Hypomagnesemia: A Rare Cause of Movement Disorders, Myopathy and Vertical Nystagmus

Ray S, Kamath VV, Jadhav SR, Rajesh KN.

Mov Disord Clin Pract. 2023 Apr 12;10(6):1001-1003. doi: 10.1002/mdc3.13735. eCollection 2023 Jun.

Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome

Deniz A, Alikılıç D, Öztürk M, Karaca Ö, Güngör M, Kara B.

J AAPOS. 2023 Apr;27(2):110-112. doi: 10.1016/j.jaapos.2022.12.001. Epub 2023 Jan 31.

A boy with a progressive neurologic decline harboring two coexisting mutations in KMT2D and VPS13D

Chang YM, Pan YW, Chou YY, Yu WH, Tsai MC.

Brain Dev. 2023 Nov;45(10):603-607. doi: 10.1016/j.braindev.2023.08.001. Epub 2023 Aug 18.

A Rare Clinical and Radiological Presentation of Neurosyphilis

Jakhar R, Mehta S, Chakravarty K, Ahuja CK, Lal V.

Mov Disord Clin Pract. 2023 Jul 11;10(8):1207-1210. doi: 10.1002/mdc3.13830. eCollection 2023 Aug.

Deep brain stimulation in a patient with progressive myoclonic epilepsy and ataxia due to potassium channel mutation (MEAK). A case report and review of the literature

Sobstyl M, Kożuch N, Iwaniuk-Gugała M, Stapińska-Syniec A, Konopko M, Jezierski P.

Epilepsy Behav Rep. 2023 Oct 11;24:100627. doi: 10.1016/j.ebr.2023.100627. eCollection 2023.

Cerebrospinal Fluid Anti-Neuronal Autoantibodies in COVID-19-Associated Limbic Encephalitis with Acute Cerebellar Ataxia and Myoclonus Syndrome: Case Report and Literature Review

Yiannopoulou K, Vakrakou AG, Anastasiou A, Nikolopoulou G, Sourdi A, Tzartos JS, Kilidireas C, Dimitrakopoulos A.

Diagnostics (Basel). 2023 Jun 14;13(12):2055. doi: 10.3390/diagnostics13122055.

The Guillain-Mollaret triangle: a key player in motor coordination and control with implications for neurological disorders

Ogut E, Armagan K, Tufekci D.

Neurosurg Rev. 2023 Jul 20;46(1):181. doi: 10.1007/s10143-023-02086-1.

Novel NUS1 variant in a Chinese patient with progressive myoclonus epilepsy: a case report and systematic review

Ji C, Zhao J, Zhang J, Wang K.

Neurol Sci. 2023 Oct;44(10):3495-3498. doi: 10.1007/s10072-023-06851-4. Epub 2023 May 30.

Ocular Flutter-Myoclonus-Ataxia Syndrome After mRNA BNT162b2 COVID-19 Vaccine: A Case Report

Poyraz T, Varol A, Uysal HA.

Noro Psikiyatr Ars. 2023 Nov 16;60(4):376-379. doi: 10.29399/npa.28205. eCollection 2023.

Systematic approach to diagnosing suspected Creutzfeldt-Jakob disease

Rode MM, Itoh C, Martinez-Sosa S, Ebner BA, Chang BK, Flanagan EP, Pinto MV.

BMJ Case Rep. 2023 Dec 7;16(12):e255174. doi: 10.1136/bcr-2023-255174.

A Rare Case of Opsoclonus Myoclonus Ataxia Syndrome Post Viral Illness

Shah NS, Pathak J, Shah PC, Bharmal UF, Ansari MI.

Cureus. 2023 Jun 14;15(6):e40396. doi: 10.7759/cureus.40396. eCollection 2023 Jun.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias